Visby Medical is a diagnostics company that develops PCR-based diagnostic tests for the detection of infectious diseases.
Visby Medical is a diagnostics company that develops PCR-based diagnostic tests for the detection of infectious diseases. The company develops a device platform that aims to redefine the way an illness is tested and treated. They believe that by taking a human-centric, technology-first approach to device development and they can create tools that are both highly accurate and delightful to use.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Jun 29, 2022 | Series E | $35M | 8 | Lightrock | — | Detail |
Mar 22, 2022 | Grant | $25.50M | 1 | Biomedical Advanced Research and Development Authority (BARDA) | — | Detail |
Mar 1, 2022 | Series E | $100M | 9 | Ping An Global Voyager | — | Detail |
Feb 2, 2021 | Grant | $12.30M | 1 | Biomedical Advanced Research and Development Authority (BARDA) | — | Detail |
May 4, 2020 | Series D | $70M | 5 | Cedars Sinai | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Lightrock | Yes | Series E |
Biomedical Advanced Research and Development Authority (BARDA) | Yes | Grant |
Ping An Global Voyager | Yes | Series E |
Hutchison Port Group | Yes | Series C |
Plug and Play | Yes | Series C |
Artiman Ventures | — | Series E |
Blue Water Life Science Advisors | — | Series E |
Cedars Sinai | — | Series E |
J-Ventures | — | Series E |
John Doerr | — | Series E |